TEBio-Techne TECH · NASDAQ
$72.57 +0.07% (+$0.05)
- Market cap
- $11.4B
- Enterprise value
- $11.4B
- P/E
- 62.4x
- Forward P/E
- 36.7x
- PEG
- 0.4x
- P/S
- 9.3x
- P/FCF
- 43.1x
- EV/EBITDA
- 33.1x
- ROIC
- 7.9%
- Bruto marža
- 65.8%
- Neto marža
- 15.0%
- Dividend yield
- 0.44%
- Payout ratio
- 27.5%
- Neto dolg/EBITDA
- 0.0x
- Beta
- 1.30
- Free float
- 99.4%
O podjetju
Bio-Techne Corporation (TECH) is a leading global biotechnology company specializing in providing tools, reagents, and technologies for research in the fields of biology and medicine. The company offers a wide range of products, including proteins, antibodies, genetic materials, and other molecular tools, enabling researchers to conduct advanced studies at the molecular level. With a commitment to innovation and quality, Bio-Techne Corporation has gained the trust of the scientific community worldwide. Shares of Bio-Techne Corporation (TECH) can be an appealing choice for investors tracking the advancements in scientific research and biotechnology.
Sector
Healthcare
Industry
Biotechnology
CEO
Kim Kelderman
Employees
3,000
Headquarters
Minneapolis
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke